US EditionPublished • loading... • Updated
Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics
Summary by The Motley Fool
1 Articles
1 Articles
Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics
Key PointsThis isn't the first time the U.S. pharmaceutical giant has signed a big-ticket partnership deal with a peer.Seamless Therapeutics, based in Germany, specializes in advanced gene-editing technology.10 stocks we like better than Eli Lilly › Much of Eli Lilly's (NYSE: LLY) recent popularity as a stock is due to its obesity drug Zepbound. While it's understandable that investors are excited about how quickly and effectively the company ha…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
